Summary
Practically no human research exists; all parameters are based on scattered user reports of 5-AEDB sold online between 2019-2024 and extrapolation from related benzofurans (5-APB, 5-APDB). Potency appears roughly 60-70% of 5-APB by weight and markedly shorter in duration. Users frequently report pronounced peripheral stimulation (increased heart rate and blood pressure) compared with MDMA, alongside moderate empathogenic warmth and mild visual enhancement. Severe vasoconstriction, bruxism, and nystagmus have been described at doses above 100 mg. Because reagent reactions overlap with 5-APDB and other APBs, professional analysis (FT-IR/GC-MS) is recommended.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | - | - | - | 130+mg(NOTADVISED)+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | After Effects |
|---|---|---|---|---|---|
| Oral | 45-90 min | 30-60 min | 1.5-3 hrs | 1-2 hrs | 2-6 hrs |
Tolerance
Build-up
develops rapidly after a single use (serotonergic psychedelic)
Reset
7–14 days for baseline
Effects
Positive
- Anxiolysis
- Stimulation
Negative
- Teeth grinding
- Vasoconstriction
- Pupil dilation
- Temperature regulation suppression
- Increased heart rate
- Nausea
- Difficulty sleeping
- Difficulty urinating
Positive
- Euphoria
- Empathy and prosocial feelings
- Alertness enhancement
- Wakefulness
- Increased sociability
- Mood lift
Negative
- Anxiety
- Talkativeness
- Time distortion
- Thought acceleration
Positive
- Tactile enhancement
- Visual tracers
- Increased music appreciation
- Bodily control enhancement
- Increased libido
- Tracers
- Visual acuity enhancement
Negative
- Light sensitivity
- Auditory hallucination
- Auditory distortion